Vahanian & Associates Financial Planning’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-528	Closed	-$369K	–	59
2022 Q1	$369K	Sell	528 -526	-50%	-$368K	0.85%	32
2021 Q4	$666K	Buy	+1,054	New	+$666K	0.54%	47